Delivery Order SPE2DB20D1100-SPE2DB25FE0TF
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,610.48 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day transdermal patches (3-unit supply) on June 20, 2025, with an ultimate completion date of June 23, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a delivery order valued at $1,983.30 to AmerisourceBergen Drug Corp for XULANE 150-35 mcg/day transdermal patches (3-count units) on August 20, 2025, with completion expected by August 21, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,038.24 on August 19, 2025, for the supply of Xulane 150-35 mcg/day transdermal patches (3-pack units). This is a firm fixed price, competitively awarded delivery order with no set-aside designation, due for completion by August 20, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child transaction...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,041.64 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day transdermal patches (3-pack quantity) on September 10, 2025, with completion scheduled for September 11, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-unit package) with a ceiling value of $2,137.02. This non-competitive delivery order, awarded on September 3, 2025, represents a firm fixed-price transaction with an ultimate completion date of September 4, 2025. The contractor will fulfill this order from its facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $10,623.13 to AmerisourceBergen Drug Corp for XULANE 150-35 MCG/DAY patches (a three-pack contraceptive transdermal patch). This firm fixed price, competitively awarded delivery order is scheduled for completion by September 22, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a non-set-aside procurement executed through the agency's established...
- The Defense Logistics Agency awarded a delivery order valued at $1,320.39 to AmerisourceBergen Drug Corp for XULANE 150-35 mcg/day transdermal patches (3-count units) on August 19, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $2,948.40 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day transdermal patches (3-count package), effective August 26, 2025, with completion targeted for August 27, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performs under this delivery order at its corporate office location....
- The Defense Logistics Agency awarded a $3,145.59 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for Xulane 150-35 mcg/day contraceptive patches (quantity of 3). This contract is a firm fixed price delivery order with an ultimate completion date of August 20, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a primary pharmaceutical distributor for federal medical procurement needs,...
- The Defense Logistics Agency awarded a delivery order valued at $3,793.09 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-unit supply) on August 27, 2025, with completion scheduled for August 28, 2025. This non-competitive delivery order was placed under firm fixed pricing terms and will be performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania. AmerisourceBergen is a major pharmaceutical distributor and critical federal medical...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE0TFDelivery Order
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Xulane 150-35 mcg/day transdermal patches in quantities of three units. This firm fixed-price delivery order, valued at $2,636.95, represents a non-competitive award under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The ultimate completion date is scheduled for September 23, 2025, and the product will be supplied from AmerisourceBergen's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement supporting military and veteran healthcare systems. The parent IDC contract functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard. This specific delivery order exemplifies the company's role in fulfilling routine pharmaceutical procurement needs under its established federal contract framework, continuing its long-standing relationship as a primary supplier within the DLA medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 9/22/25 |